Student or educator? Sign up with your school email and get 6 months of Pro free.
Cited by 192

The DOI matches its Crossref record; 1 of the 1 references it cites were found in a registry or an index.

Downregulation of LncRNA GAS5 causes trastuzumab resistance in breast cancer

Open access
Li, Wentong, Zhai, Limin, Wang, Hui, Liu, Chuanliang, Zhang, Jinbao, Chen, Weijuan, Wei, Qun · 2016 · Oncotarget

Abstract

// Wentong Li 1 , Limin Zhai 1 , Hui Wang 2 , Chuanliang Liu 3 , Jinbao Zhang 4 , Weijuan Chen 5 , Qun Wei 5 1 Department of Pathology, Weifang Medical University, Weifang, Shandong Province, 261053, P.R. China 2 Department of Oncology, People’s Hospital of Shouguang City, Shandong Province, 262700, P.R. China 3 Department of Health Care, Weifang People’s Hospital, Weifang, Shandong Province, 261053, P.R. China 4 Department of Molecular Genetics, Weifang Medical University, Weifang, Shandong Province, 261053, P.R. China 5 Department of Pathology, People’s Hospital of Shouguang City, Shandong Province, 262700, P.R. China Correspondence to: Wentong Li, e-mail: liwentong11@163.com Keywords: trastuzumab, lapatinib, drug resistance, lncRNA GAS5, mTOR Received: January 28, 2016 Accepted: March 16, 2016 Published: March 28, 2016 ABSTRACT Therapeutic resistance to trastuzumab caused by dysregulation of long noncoding RNAs (lncRNAs) is a major obstacle to clinical management of HER2-positive breast cancer. To investigate which lncRNAs contribute to trastuzumab resistance, we screened a microarray of lncRNAs involved in the malignant phenotype of trastuzumab-resistant SKBR-3/Tr cells. Expression of the lncRNA GAS5 was decreased in SKBR-3/Tr cells and in breast cancer tissue from trastuzumab-treated patients. Inhibition of GAS5 promoted SKBR-3 cell proliferation, and GAS5 knockdown partially reversed lapatinib-induced inhibition of SKBR-3/Tr cell proliferation. GAS5 suppresses cancer proliferation by acting as a molecular sponge for miR-21, leading to the de-repression of phosphatase and tensin homologs (PTEN), the endogenous target of miR-21. Moreover, mTOR activation associated with reduced GAS5 expression was required to suppress PTEN. This work identifies GAS5 as a novel prognostic marker and candidate drug target for HER2-positive breast cancer.

Overview

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Integrity signals

Registry

Crossref · 10.18632/oncotarget.8413

Cites

1 of 1 references verified0 citation errors · 0 not checkable

Statistics

Verification

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

A few free checks a day · papers already verified open instantly · results are public

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

Citations

Cited by

Metadata

Authors
Li, W., Zhai, L., Wang, H., Liu, C., Zhang, J., Chen, W., & Wei, Q.
Venue
Oncotarget
Published
2016-03-28
Volume
7
Issue
19
Pages
27778-27786
ISSN
1949-2553 (ISSN-L)
OpenAlex
W2314065766
Cited by
192
References
1
FWCI
12.01
Type
journal article
Language
en
Open access
diamond

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Data sources

Bibliographic data: Semantic Scholar, OpenAlex, Crossref.

Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).

Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.